prothrombin

美 [proʊ'θrɒmbɪn]英 [prə'θrɒmbɪn]
  • n.【生化】凝血酶原
  • 网络凝血素;凝血原;凝血酵素原

prothrombinprothrombin

prothrombin

凝血酶原

凝血酶原prothrombin)活化成凝血酶时,须下列何种矿物质?…001来源: 95年第一次专技高普考试医事人员~营养师(营养 …

凝血素

让翻译吐血的医学会议同传_汤永恒_新浪博客 ... thrombokinase 凝血激酶 Prothrombin 凝血素 Thrombin 凝血酶 ...

凝血原

凝血原(Prothrombin)在凝血过程中,可以变为凝血促使 正常值: 凝血原时间的长短,因实验室的温度、设备和方法而不 同。

凝血酵素原

系为形成凝血酵素原Prothrombin)不可缺的物质。主要生理机能:

凝血因子

  1.催化肝合成凝血因子prothrombin)----->促凝血,加快其速率。   2.将麸胺酸转化为γ-carboic麸胺酸,参与生化酵素反应。

凝血脢原

凝血脢原(Prothrombin)在肝脏中合成,在血栓形成激素(Thromboplastin)的作用下﹐转变成凝血脢(Thrombin)﹐为血液凝固的必 …

全凝血霉

紫斑症 -... ... Ⅰ .纤维素原( Fibrinogen) Ⅱ .全凝血霉( Prothrombin) Ⅲ .组织血栓形成素( Tissue thromboplastin) ...

1
Annexin V inhibits prothrombin activation and is able to prevent thrombus formation under normal venous and arterial blood flow conditions. 膜联蛋白V抑制凝血酶原激活,并能防止血栓形成正常静脉和动脉血流情况。
2
Dosage should be controlled by periodic determinations of prothrombin time(PT) or other suitable coagulation tests. 必须定期检查凝血酶原时间(PT),或做其他相应的凝血试验来控制剂量。
3
Results AFP, albumin, prealbumin, and prothrombin time were correlated with the inflammation grade of the liver. 结果甲胎蛋白、白蛋白、前白蛋白、凝血酶原时间与病理学炎症分级有关;
4
The platelet count's down to a thousand. Prothrombin time's way up at thirty, and he's got fibrin degradation products. 血小板计数下降到1000,凝血原酶时间上升到30,而且血液中有纤维蛋白降解产物。
5
Objective To investigate a possible association between the mutation of human prothrombin gene G20210A and coronary heart disease (CHD). 目的探讨凝血酶原基因G20210A突变与中国汉族人群冠心病的相关性。
6
Activated partial thromboplastin time (APTT), prothrombin time (PT) and thrombin time (TT) were evaluated by test tube method in rabbit. 采用试管法测定新西兰兔活化部分凝血活酶时间(APTT),凝血酶辱、时间(PT)和凝血酶时间(PT)。
7
infusion of prothrombin complex matter, fresh blood and plasma fibrinogen, platelet concentrate, etc. 输注凝血酶原复物、新鲜血液和血浆、浓缩血小板、纤维蛋白原等;
8
The production method has the advantages that content of the product prothrombin and oligosaccharide is less, and the nutrition is rich. 本发明具有制作出的产品凝血素和寡糖含量较少、营养较丰富的优点。
9
2What drugs alter prothrombin time by interacting with warfarin levels (pharmacokinetics)? 2哪些药物可通过影响华法林水平改变凝血酶原时间(药代动力学角度)?更详细。
10
Objective To evaluate the treatment of plasma exchange (PE) in patients with chronic severe hepatitis based on prothrombin activity ( PTA ). 目的探讨根据凝血酶原活动度(PTA)预测重型肝炎高胆红素血症行血浆置换的临床疗效。
11
3What drugs alter prothrombin time, but not by changing warfarin levels (pharmacodynamics)? 3哪些药物不是通过影响华法林水平而改变凝血酶原时间(药效动力学角度)?更详细。
12
Study of Every Kind of Different Thromboplastin Reagents in Detection of Prothrombin Time 各种不同凝血活酶试剂测定凝血酶原时间的研究
13
Contrasting observation of the effect on the result of prothrombin time by different approach of blood sampling 不同途径采血对凝血酶原时间影响的对比观察
14
Study of the relation between prothrombin gene mutation and cerebral thrombosis 凝血酶原基因突变与脑血栓形成关系探讨
15
Study of the Relation between Prothrombin Gene Mutation and Thrombosis 凝血酶原基因突变与血栓形成的关系
16
Relationship Between Plasma Prothrombin Activity and Histology of the Liver in Patients with Viral Hepatitis 病毒性肝炎血浆凝血酶原活动度与肝组织病变程度的关系
17
Clinical Application of Plasma Cholinesterase, Prothrombin Activity and Albumin in Patients with Viral Hepatitis 血浆胆碱酯酶、凝血酶原活动度及清蛋白在病毒性肝炎中的临床应用
18
Relationship between cholinesterase, prothrombin activity and albumin and the pathology of the liver 胆碱酯酶、凝血酶原活动度及白蛋白与肝组织病理损害关系的研究
19
Detection and clinical application of abnormal prothrombin in the diagnosis of hepatocellular carcinoma 异常凝血酶原含量的测定及其在肝癌诊断中的临床应用
20
Advance in Fractionation and Purification for Human Prothrombin Complex Concentrates 人凝血酶原复合物分离纯化工艺的研究进展
21
Selection of the reporting form of prothrombin time in patients with liver failure 肝衰竭患者凝血酶原时间报告形式的探讨
22
Application of Precursor of Prothrombin in Monitoring of Anticoagulation Effect for Warfarin 凝血酶原前体蛋白在华法林抗凝效果监测中的应用
23
Establishment of local international sensitivity index of instrument in the prothrombin 血浆凝血酶原时间测定中建立仪器区域国际敏感指数的实验探讨
24
Clinical significance of plasma prothrombin activity in patients with severe hepatitis 重型肝炎患者血浆凝血酶原活动度动态变化及其意义
25
Significance of Plasmal Prothrombin Coagulative Activity to Evaluate Old Age with Liver Diseases 检测老年肝病患者血浆凝血酶原活性的临床价值
26
The Factors That Influence the Consistency of International Normalized Ratio of Prothrombin Time 影响凝血酶原时间国际标准化比值一致性的因素
27
Study on Prothrombin Time of Susceptible Rattus norvegicus in Nanjing Region 南京地区敏感褐家鼠凝血酶原时间的研究
28
Standardization of prothrombin time with the instrumental method 仪器法测定凝血酶原时间的标准化
29
Exploration of the standardization of prothrombin time 凝血酶原时间测定标准化的几点探讨
30
Investigation of Influence Factor in Determination of Prothrombin Time 对血浆凝血酶原时间测定影响因素的探讨